[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1979

Periodic PeritonitisPresent Management and Future Prospects

Author Affiliations

From Medical City, Department of Medicine, University of Baghdad, Baghdad, Iraq.

Arch Intern Med. 1979;139(7):781-783. doi:10.1001/archinte.1979.03630440043015
Abstract

Thirty-three patients with periodic peritonitis were treated with colchicine for 863 patient-months of observation (average, 27 months). There is a personal optimum dose, and the daily requirement varies at 1 or 1.5 mg. All patients responded to treatment. Episodes were precipitated in all patients who stopped their medications. No side effects were noticed. Four normal full-term infants were born to patients taking colchicine during the study.

(Arch Intern Med 139:781-783, 1979)

×